Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
*Terms and restrictions may apply for certain doses When it comes to the above weight loss injections and their costs, there are several points to keep in mind: Some of these medications ( Ozempic , Mounjaro ) are not approved by the US Food and Drug Administration (FDA) for weight loss
Summary: Retatrutide FDA Status Retatrutide is not FDA-approved and won't be for at least another year It's in Phase 3 trials (TRIUMPH program) with results expected in late 2026 FDA approval is projected for 20272028 Phase 2 data showed 24.2% weight loss , better than any approved GLP-1 medication Current access: clinical trials (free), compounded retatrutide ($200$500/mo), or research peptides ($150$500/mo) When approved, retatrutide will be the first triple-agonist obesity medication on the market References Jastreboff AM, Aronne LJ, Ahmad NN, et al
Same medication, different indication and dosing
doi: 10.1016/j.ajpath.2020.09.013 188 van GentRDi SanzaCvan den BroekNJFleskensVVeenstraAStoutGJet al
Distribution and reuse of 76Se-selenosugar in selenium-deficient rats
[DOI] [PMC free article] [PubMed] [Google Scholar] 403
US$ 29.54
US$ 21.14
US$ 28.59
US$ 27.35
US$ 27.11
US$ 27.44
